Clinical trials: Difference, Individual

Healthy

A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated

• Completed
• Age: 18 to 80 years
• Phase 1
• Results posted

The main objectives of this trial are to investigate safety and tolerability of BI 474121 in healthy male and female young and elderly subjects following oral administration of multiple rising doses per day over 14 days.

Trial name

NCT04537897

Testing

BI 474121, Midazolam

Where

Germany

Volunteers

70 people, healthy volunteers welcome

Sponsor

Boehringer Ingelheim